China Medicine Stock Price Patterns
| CHME Stock | USD 0.04 0.00 0.00% |
Momentum 60
Buy Extended
Oversold | Overbought |
Using China Medicine hype-based prediction, you can estimate the value of China Medicine from the perspective of China Medicine response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in China Medicine to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying China because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
China Medicine after-hype prediction price | USD 0.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
China |
China Medicine After-Hype Price Density Analysis
As far as predicting the price of China Medicine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in China Medicine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of China Medicine, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
China Medicine Estimiated After-Hype Price Volatility
In the context of predicting China Medicine's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on China Medicine's historical news coverage. China Medicine's after-hype downside and upside margins for the prediction period are 0.00 and 8.32, respectively. We have considered China Medicine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
China Medicine is out of control at this time. Analysis and calculation of next after-hype price of China Medicine is based on 3 months time horizon.
China Medicine Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as China Medicine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading China Medicine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with China Medicine, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 8.35 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.04 | 0.04 | 14.29 |
|
China Medicine Hype Timeline
China Medicine is currently traded for 0.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. China is expected to increase in value after the next headline, with the price projected to jump to 0.04 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is estimated to be 14.29%, whereas the daily expected return is currently at 0.16%. The volatility of related hype on China Medicine is about 0.0%, with the expected price after the next announcement by competition of 0.04. China Medicine currently holds 4.05 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. China Medicine has a current ratio of 10.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist China Medicine until it has trouble settling it off, either with new capital or with free cash flow. So, China Medicine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Medicine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Medicine's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next expected press release will be in 5 to 10 days. Check out China Medicine Basic Forecasting Models to cross-verify your projections.China Medicine Related Hype Analysis
Having access to credible news sources related to China Medicine's direct competition is more important than ever and may enhance your ability to predict China Medicine's future price movements. Getting to know how China Medicine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how China Medicine may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TBIO | Telesis Bio | 0.00 | 0 per month | 0.00 | 0.20 | 284.62 | (40.00) | 824.84 | |
| USPS | Ultimate Sports | 0.00 | 0 per month | 0.00 | (0.21) | 0.00 | 0.00 | 9.09 | |
| CHYPF | Health Logic Interactive | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EPGNF | Epigenomics AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PCYN | Procyon | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 8.33 | |
| OVATF | Ovation Science | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CTTH | CTT Pharmaceutical Holdings | 0.00 | 0 per month | 8.54 | 0.08 | 21.39 | (15.58) | 70.25 | |
| DTRK | DATATRAK International | 0.00 | 0 per month | 8.37 | 0.03 | 16.47 | (17.65) | 74.42 | |
| UNBX | Unity Biotechnology | 0.00 | 0 per month | 11.01 | 0.01 | 22.58 | (17.00) | 87.87 | |
| PPJE | PPJ Healthcare Enterprises | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
China Medicine Additional Predictive Modules
Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About China Medicine Predictive Indicators
The successful prediction of China Medicine stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as China Medicine, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of China Medicine based on analysis of China Medicine hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to China Medicine's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to China Medicine's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for China Pink Sheet analysis
When running China Medicine's price analysis, check to measure China Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medicine is operating at the current time. Most of China Medicine's value examination focuses on studying past and present price action to predict the probability of China Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medicine's price. Additionally, you may evaluate how the addition of China Medicine to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |